Navigation Links
When it comes to health, all chocolates not the same.

ark chocolate and milk chocolate in the lab. Dark chocolate had twice as much, in part because milk chocolate contains only about half as much actual chocolate.

The researchers then gave chocolate bars to seven women and five men who were between 25 and 35 years old. All of the participants were nonsmokers, had normal blood lipid levels, took no prescription drugs or vitamins and were not overweight.

After they ate dark chocolate bars, the antioxidant potential measured in their blood increased an average of 18 percent and remained elevated for three hours.

Thus researchers say the subjects antioxidant potential did not rise noticeably when they consumed a glass of whole milk with the dark chocolate, or when they ate milk chocolate. He said it's possible that antioxidants bind with milk proteins making absorption more difficult. Scientists who did not contribute to the research said the protective aspects of flavonoids in chocolate have not been proven.

"I guess this means to be healthy you should eat chocolate with red wine," said Andrew L. Waterhouse, a nutrition professor at the University of California at Davis. "That is, if you believe the antioxidant hypothesis.

"No one has taken flavonoids, given them to people in a controlled scenario and shown that people who take them are more healthy than those who don't," he said.

Thus there is not enough information to recommend chocolate as a food that reduces the risk of heart disease.
'"/>




Page: 1 2

Related medicine news :

1. Now AIDS treatment comes dirt-cheap
2. Shorter infants have lower incomes in later life
3. Joint replacement surgery outcomes may be affected by obesity and diabetes
4. Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement
5. Gene Therapy Overcomes Heart Failure In Muscular Dystrophy
6. Testicular Cancer Patients Have Improved Reproductive Outcomes After Treatment
7. India becomes a member of IARC
8. PET Scans Could Predict Treatment Outcomes In Cancer
9. Nutrigenomics here comes a team to better your future!
10. Inhuman Error: Medicine Becomes Poison, Causing Death
11. Prostate Cancer Outcomes Determined By Socioeconomic Status
Post Your Comments:
Breaking Medicine Technology:BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Andrews Institute for Orthopaedics and Sports Medicine Now Providing Free Orthopaedic Exams and Assessments on Saturday Mornings to Student Athletes 55929 1Andrews Institute for Orthopaedics and Sports Medicine Now Providing Free Orthopaedic Exams and Assessments on Saturday Mornings to Student Athletes 55929 2Andrews Institute for Orthopaedics and Sports Medicine Now Providing Free Orthopaedic Exams and Assessments on Saturday Mornings to Student Athletes 55929 3American Imaging Management Reacts to New England Journal of Medicine Articles on Diagnostic Imaging 55925 1American Imaging Management Reacts to New England Journal of Medicine Articles on Diagnostic Imaging 55925 2Trauma 411 3A Prolonged Surgery Should be Avoided in Certain Cases 4932 1Trauma 411 3A Prolonged Surgery Should be Avoided in Certain Cases 4932 2Trauma 411 3A Prolonged Surgery Should be Avoided in Certain Cases 4932 3
Other Medicine Technology:Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 2Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 3Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 4Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 5Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 6Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 3Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 4